APA (7th ed.) Citation

Han, F., Pan, H., Yang, Y., Chen, J., Xue, J., Lan, L., . . . Jin, L. Belimumab versus telitacicept in sequential treatment after rituximab for refractory lupus nephritis: A real-world multicentre study. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Han, Fei, et al. Belimumab Versus Telitacicept in Sequential Treatment After Rituximab for Refractory Lupus Nephritis: A Real-world Multicentre Study. BMJ Publishing Group.

MLA (9th ed.) Citation

Han, Fei, et al. Belimumab Versus Telitacicept in Sequential Treatment After Rituximab for Refractory Lupus Nephritis: A Real-world Multicentre Study. BMJ Publishing Group.

Warning: These citations may not always be 100% accurate.